Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
25.43
-0.75 (-2.86%)
Nov 20, 2024, 4:00 PM EST - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.24 billion as of November 21, 2024. Its market cap has increased by 145.47% in one year.
Market Cap
1.24B
Enterprise Value
950.74M
1-Year Change
145.47%
Ranking
Category
Stock Price
$25.43
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.24B, an increase of 27.56%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.28B | 124.26% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evolent Health | 1.30B |
| STAAR Surgical Company | 1.30B |
| Novavax | 1.29B |
| AdaptHealth | 1.28B |
| Cassava Sciences | 1.25B |
| Kura Oncology | 1.24B |
| Pediatrix Medical Group | 1.22B |
| Maravai LifeSciences Holdings | 1.22B |